What's new
This page lists items that we have published for the first time or updated in the last 7, 30 or 60 days. Use the filters to narrow results by audience, product type, content type or topic.
You can also stay informed by:
- subscribing to our updates to receive same-day notification emails on safety information, scheduling updates or media releases.
- checking for open consultations.
- joining any upcoming events.
This page is in Beta testing. We welcome your feedback and suggestions as we look to improve this page.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (11)
- Committees and advisory bodies (6)
- Compliance and enforcement (11)
- Cosmetics (1)
- Import and export (7)
- Labelling and packaging (3)
- Legislation (3)
- Manufacturing (5)
- Safety monitoring and information (20)
- Scheduling (national classification system) (6)
- Shortages and supply disruptions (8)
- Sunscreens (3)
- Unique Device Identification (UDI) hub (3)
- Vaping hub (5)
- Weight loss products (1)
What's new
95 result(s) found, displaying 76 to 95
-
GuidanceFind out how TGA regulates software and artificial intelligence (AI) based medical devices.
-
Prescription medicine decision summaryAdzynma (apadamtase alfa/ cinaxadamtase alfa) has been approved for the treatment of ADAMTS13 deficiency in adults and children with congenital thrombotic thrombocytopenic purpura (cTTP).
-
TopicWe monitor and enforce compliance with laws that regulate health products.
-
PageFind out how we approach and manage compliance with therapeutic goods regulation in Australia.
-
PageRead about our new priority areas for compliance activities relating to the import, advertising and supply requirements of the Therapeutic Goods Act 1989 from 2023 to 2025.
-
Scheduling decisions (final)This web publication constitutes a notice for the purposes of regulation 42ZCZS of the Therapeutic Goods Regulations 1990 (the Regulations).
-
PageSummary of legal settings relevant to the prescribing and dispensing of therapeutic nicotine vaping goods to patients under 18 years of age.
-
Scheduling submissionsFind out about the public submissions on scheduling matters referred to the ACMS
-
PageRecall coordinators play an important part in the market action process.
-
Media releasesThe TGA Compliance Principles 2026 and 2027 outlines our strategic approach to monitoring and enforcing regulatory compliance for the import, export, manufacture, supply and advertising of therapeutic goods in Australia.
-
Meeting statementsAdvisory Committee on Vaccines meeting statement 54
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
GuidanceThis guidance is to assist you to apply for a Certificate of Free Sale or an Export Certificate for medical devices, including in-vitro diagnostic medical devices (IVDs) and Other Therapeutic Goods (OTGs).
-
Scheduling decisions (final)This web publication constitutes a notice for the purposes of regulation 42ZCZS and regulation of the 42ZCX Therapeutic Goods Regulations 1990 (the Regulations).
-
PageIndividuals can legally import most therapeutic goods for personal use under the Personal Importation Scheme, provided certain conditions are met.
-
PageLearn more about the TGA's post-market review of mercury-containing medical devices.
-
Scheduling submissionsFind out about the public submissions on scheduling matters referred to the ACMS, ACCS & Joint ACMS-ACCS MARCH, 2024
-
PageInformation about the shortages of HRT products for patients and healthcare professionals
-
Media releasesAn individual has been sentenced for unlawfully advertising and supplying black salve and bloodroot capsules, and for advertising other unapproved therapeutic goods to treat serious conditions such as anxiety.
-
Safety updatesInformation for health professionals about medicines with safety related updates to their Product Information.